Not often does a company go through so many changes in so little time, from acquisitions to novel businesses to management changes. But if there is a company that can go through restructuring and come out on top, it’s Celera Genomics. Celera has made noticeable progress of late on its path from genomics database provider to fully integrated drug discovery company. And it has become a favorite of investors as its foray into drug development and molecular diagnostics has begun to crystallize.